Positronenemissionstomographie gestützte Behandlung des Morbus Hodgkin im frühen günstigen Stadium: Endergebnisse der Deutschen Hodgkin Studiengruppe (DHSG)

Author:

Frerker Bernd,Hildebrandt Guido

Funder

Universitätsmedizin Rostock

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Reference24 articles.

1. Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A et al (2019) HD16 – positron emission tomography-guided treatment in early-stage favorable Hodgkin Lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin study group. HD16 trial. J Clin Oncol 37:2835–2845. https://doi.org/10.1200/JCO.19.00964

2. Dühmke E, Franklin J, Pfreundschuh M, Sehlen S, Willich N et al (2001) HD04 – Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin’s disease: long-term results of a randomized trial of radiotherapy alone. HD04 trial. J Clin Oncol 19:2905–2914. https://doi.org/10.1200/JCO.2001.19.11.2905

3. Engert A, Franklin J, Eich HT, Brillant C, Sehlen S et al (2007) HD07 – Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin’s lymphoma: final results of the GHSG HD7 trial. HD07 trial. J Clin Oncol 25:3495–3502. https://doi.org/10.1200/JCO.2006.07.0482

4. Engert A, Plütschow A, Eich HT, Lohri A, Dörken B et al (2010) HD10 – Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. HD10 tri. N Engl J Med 363:640–652. https://doi.org/10.1056/NEJMoa1000067

5. Specht L, Gray RG, Clarke MJ, Peto R (1998) Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin’s disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin’s Disease Collaborative Group. J Clin Oncol 16:830–843. https://doi.org/10.1200/JCO.1998.16.3.830

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3